Free Trial

T2 Biosystems (TTOO) Competitors

T2 Biosystems logo
$0.18 -0.05 (-22.08%)
As of 02/21/2025 03:59 PM Eastern

TTOO vs. CTCX, CHEK, TNON, SINT, HSCS, AMIX, NDRA, GMVDF, BBLG, and VERO

Should you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include Carmell (CTCX), Check-Cap (CHEK), Tenon Medical (TNON), Sintx Technologies (SINT), Heart Test Laboratories (HSCS), Autonomix Medical (AMIX), ENDRA Life Sciences (NDRA), G Medical Innovations (GMVDF), Bone Biologics (BBLG), and Venus Concept (VERO). These companies are all part of the "medical equipment" industry.

T2 Biosystems vs.

Carmell (NASDAQ:CTCX) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings.

24.2% of Carmell shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 29.0% of Carmell shares are owned by insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Carmell has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Carmell's return on equity.

Company Net Margins Return on Equity Return on Assets
CarmellN/A -217.50% -50.22%
T2 Biosystems -563.16%N/A -174.06%

Carmell has higher earnings, but lower revenue than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CarmellN/AN/A-$15.44MN/AN/A
T2 Biosystems$7.19M0.53-$50.08MN/AN/A

Carmell has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500.

In the previous week, T2 Biosystems had 4 more articles in the media than Carmell. MarketBeat recorded 4 mentions for T2 Biosystems and 0 mentions for Carmell. Carmell's average media sentiment score of 0.00 beat T2 Biosystems' score of -0.30 indicating that Carmell is being referred to more favorably in the media.

Company Overall Sentiment
Carmell Neutral
T2 Biosystems Neutral

T2 Biosystems received 406 more outperform votes than Carmell when rated by MarketBeat users.

CompanyUnderperformOutperform
CarmellN/AN/A
T2 BiosystemsOutperform Votes
406
63.24%
Underperform Votes
236
36.76%

T2 Biosystems has a consensus price target of $5.00, indicating a potential upside of 2,677.78%. Given T2 Biosystems' stronger consensus rating and higher probable upside, analysts plainly believe T2 Biosystems is more favorable than Carmell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Carmell
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
T2 Biosystems
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Carmell beats T2 Biosystems on 7 of the 13 factors compared between the two stocks.

Get T2 Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TTOO vs. The Competition

MetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4.86M$4.61B$5.81B$9.02B
Dividend YieldN/A39.91%4.77%3.84%
P/E RatioN/A24.1021.5016.68
Price / Sales0.5350.59453.1985.13
Price / CashN/A51.2243.9637.32
Price / Book-0.036.577.654.65
Net Income-$50.08M$90.13M$3.18B$245.69M
7 Day PerformanceN/A-2.20%-1.95%-2.67%
1 Month Performance-21.47%-2.17%-0.23%-2.16%
1 Year Performance-96.72%15.26%16.69%12.90%

T2 Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TTOO
T2 Biosystems
1.9716 of 5 stars
$0.18
-22.1%
$5.00
+2,677.8%
-96.8%$4.86M$7.19M0.00180Analyst Forecast
News Coverage
CTCX
Carmell
N/A$0.25
+2.5%
N/A-92.2%$5.14MN/A0.0014
CHEK
Check-Cap
0.4585 of 5 stars
$0.86
-4.3%
N/A-68.1%$5.04MN/A-0.2980Analyst Forecast
TNON
Tenon Medical
1.6955 of 5 stars
$1.46
flat
$5.50
+276.7%
+23.0%$4.58M$2.93M-0.058
SINT
Sintx Technologies
1.0193 of 5 stars
$2.95
-0.7%
N/A-82.2%$3.95M$2.63M-0.0640News Coverage
HSCS
Heart Test Laboratories
2.4753 of 5 stars
$3.91
+2.6%
$13.50
+245.3%
-69.2%$3.83M$20,000.00-0.4910Positive News
Gap Down
AMIX
Autonomix Medical
1.8698 of 5 stars
$2.84
-0.4%
$28.00
+885.9%
-96.2%$3.27MN/A-0.181News Coverage
NDRA
ENDRA Life Sciences
2.344 of 5 stars
$5.02
+0.1%
$700,000.00
+13,958,025.6%
-100.0%$2.71MN/A-0.0120Gap Up
GMVDF
G Medical Innovations
N/AN/AN/A-99.3%$2.60M$4.42M0.0072
BBLG
Bone Biologics
0.2322 of 5 stars
$1.04
+1.0%
N/A-67.9%$2.59MN/A0.002
VERO
Venus Concept
N/A$0.33
-1.0%
N/A-74.6%$2.41M$76.35M-0.04410Negative News

Related Companies and Tools


This page (NASDAQ:TTOO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners